Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 767,385,536
  • Shares Outstanding, K 950,405
  • Annual Sales, $ 34,124 M
  • Annual Income, $ 5,240 M
  • 60-Month Beta 0.37
  • Price/Sales 22.52
  • Price/Cash Flow 105.87
  • Price/Book 59.50
Trade LLY with:

Options Overview Details

View History
  • Implied Volatility 27.27% ( +2.04%)
  • Historical Volatility 30.61%
  • IV Percentile 46%
  • IV Rank 42.01%
  • IV High 38.67% on 10/26/23
  • IV Low 19.01% on 09/01/23
  • Put/Call Vol Ratio 0.65
  • Today's Volume 25,088
  • Volume Avg (30-Day) 38,319
  • Put/Call OI Ratio 0.95
  • Today's Open Interest 246,389
  • Open Int (30-Day) 268,833

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 2.65
  • Number of Estimates 9
  • High Estimate 2.95
  • Low Estimate 2.28
  • Prior Year 2.11
  • Growth Rate Est. (year over year) +25.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
729.61 +10.72%
on 04/29/24
820.60 -1.55%
on 05/23/24
+74.35 (+10.14%)
since 04/26/24
3-Month
718.30 +12.47%
on 04/25/24
820.60 -1.55%
on 05/23/24
+50.22 (+6.63%)
since 02/28/24
52-Week
422.06 +91.41%
on 05/30/23
820.60 -1.55%
on 05/23/24
+382.07 (+89.73%)
since 05/26/23

Most Recent Stories

More News
A New Name in Weight Loss Drugs

Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.

HIMS : 19.10 (+13.15%)
NVO : 134.08 (-1.44%)
LLY : 807.86 (+0.05%)
XPOF : 9.50 (+4.40%)
WIX : 165.06 (-2.91%)
Eli Lilly Bolsters Spending to Promote GLP-1s

Eli Lilly (NYSE:LLY) is an Indianapolis-based company that discovers, develops, and markets human pharmaceuticals ...

LLY : 807.86 (+0.05%)
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?

Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.

NVO : 134.08 (-1.44%)
BMO : 96.11 (+0.67%)
CTLT : 54.00 (-1.50%)
HIMS : 19.10 (+13.15%)
LLY : 807.86 (+0.05%)
10 Best Vanguard Funds to Buy Right Now

These 10 Vanguard stock ETFs can help you build a top-notch portfolio.

MSFT : 430.32 (+0.04%)
AAPL : 189.99 (+0.01%)
AMZN : 182.15 (+0.77%)
AVGO : 1,412.45 (+0.33%)
AXON : 288.20 (+0.90%)
CEG : 231.27 (+0.28%)
BRK.AX : 0.012 (-7.69%)
JPM : 199.50 (-0.60%)
TM : 218.72 (+0.87%)
JNJ : 144.38 (-1.76%)
UNH : 503.68 (-0.88%)
TDG : 1,317.94 (-2.40%)
Got $500? 3 Pharma Stocks to Buy and Hold Forever

These players might even beat the market when the conditions are right.

VRTX : 446.88 (-2.20%)
LLY : 807.86 (+0.05%)
PFE : 28.30 (-2.01%)
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?

The gold rush for obesity medications just got a bit more intense.

AMGN : 300.19 (-1.85%)
LLY : 807.86 (+0.05%)
NVO : 134.08 (-1.44%)
Where Will Novo Nordisk Be in 10 Years?

Will Novo Nordisk top $1 trillion in market value?

LLY : 807.86 (+0.05%)
NVO : 134.08 (-1.44%)
3 High-Flying Stocks That Could Soar Even More

The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.

LLY : 807.86 (+0.05%)
NVO : 134.08 (-1.44%)
VRTX : 446.88 (-2.20%)
Lexaria Bioscience (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is partnering with a contract research organization (“CRO”) to conduct its human pilot study #3. According to...

LEXX : 3.39 (+8.65%)
LEXXW : 1.1900 (-0.22%)
LLY : 807.86 (+0.05%)
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro

Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its hot-selling weight-loss and diabetes treatments, Zepbound and Mounjaro

LLY : 807.86 (+0.05%)
$SPX : 5,306.04 (+0.02%)
$DOWI : 38,852.86 (-0.55%)
$IUXX : 18,869.44 (+0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 835.91
2nd Resistance Point 822.45
1st Resistance Point 815.16
Last Price 807.86
1st Support Level 794.41
2nd Support Level 780.95
3rd Support Level 773.66

See More

52-Week High 820.60
Last Price 807.86
Fibonacci 61.8% 668.36
Fibonacci 50% 621.33
Fibonacci 38.2% 574.30
52-Week Low 422.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar